Join the DDA or

Three drugs subject to supply notifications

Locorten Vioform; Catapres; Nexium

July 22nd 2021

Tagged: supply shortages

By Ailsa Colquhoun

DHSC has announced the following tier 2 medicine supply notifications:

MedicineOut of stock untilAlternatives
Locorten Vioform (flumetasone/clioquinol) 0.02% w/v / 1% w/v ear drops solution

 

April 2022
  • Betnesol-N (Betamethasone sodium phosphate 0.1%, Neomycin sulphate 0.5%) eye/ear/nose drops
  • Otomize (Dexamethasone 0.1%, neomycin sulphate 0.5%, glacial acetic acid 2%) ear spray
  • Otosporin (Hydrocortisone 1%, neomycin sulphate 3400 units/mL, polymyxin B sulphate 10,000 units/mL) ear drops
  • Sofradex (Dexamethasone 0.05%, framycetin sulphate 0.5%, gramicidin 0.005%) ear/eye drops
  • Canesten (clotrimazole) 1% solution
Catapres (clonidine) 100 microgram tablets

 

Very limited supplies until w/c 4 October 2021.

 

  • Clonidine 25 microgram tablets
  • Clonidine 50 microgram /5ml oral solution sugar free
  • Unlicensed imports have been sourced.
Nexium (esomeprazole) 10mg gastro-resistant granules sachets

 

w/c 16 August 2021
  • Lansoprazole 15mg & 30mg orodispersible tablets
  • Omeprazole (10mg, 20mg and 40mg) dispersible gastro-resistant tablets
  • Omeprazole (2mg/ml or 4mg/ml) oral suspension sugar free (licensed)
  • Omeprazole (2mg/ml or 4mg/ml) oral solution (unlicensed)

There have also been changes to the resupply dates of the medicines listed below:

Original MSN referenceDate of original MSN/SDASupply issueResupply date originally communicatedUpdated resupply date as of w/c

19 July 2021

MSN/2021/02109/04/2021Diamorphine 5mg and 10mg injectionsw/c 19 March 2021 

5mg – End of July 2021

 

10mg –  w/c 19 July 2021